Oral solution formulation of Vimpat available

Oral solution formulation of Vimpat available
Oral solution formulation of Vimpat available

UCB announced that it has made available an oral solution formulation of Vimpat (lacosamide), an antiepileptic drug for the add-on treatment of partial-onset seizures in patients ≥17 years of age with epilepsy. Healthcare providers can convert patients between the already available tablet and intravenous injection formulations with equivalent dosing and without titration.

Vimpat is a C-V controlled substance. Vimpat oral solution is available in a 10mg/mL dosage strength.

For more information call (800) 477-7877 or visit www.vimpat.com.